Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Acetylcholine and Gossypol

supplement:

Gossypol

Research Papers that Mention the Interaction

Gossypol almost abolished the effects of acetylcholine and substance P on vascular resistance, but had no significant effect on the responses to prostaglandin E1 and glyceryl trinitrate.
Zeitschrift fur Kardiologie  •  1989  |  View Paper
2 … to acetylcholine (1 μm) were inhibited by the following … the approximate IC50 values indicated in parentheses: gossypol (1.5 μm), nordi‐hydroguairetic acid (NDGA, 5 μm), AA 861 (20 μm), phenidone (30 μm), …), BW 755C (300 μm), and piriprost (500 μm); with cirsiliol 50% inhibition was not achieved.
British journal of pharmacology  •  1988  |  View Paper
In the blood-perfused hind limb of the rabbit, two irreversible inhibitors of endothelium-dependent vasodilation gossypol and p-bromophenacyl-bromide) blocked the vasodilation induced by the endothelium-dependent agent acetylcholine , but not the response to the endothelium-independent vasodilator prostaglandin E1.(ABSTRACT TRUNCATED AT 250 WORDS)
Journal of cardiovascular pharmacology  •  1986  |  View Paper
Hemoglobin (Hb), gossypol , and N omega-nitro-L-arginine methyl ester (L-NAME), inhibitors for endothelium-derived relaxing factor (EDRF) in mammalian blood vessels, partially inhibited vasorelaxation induced by ANG II and ACh in fowl.
The American journal of physiology  •  1993  |  View Paper
Collagenase, gossypol , hemoglobin and ascorbic acid have been reported to inhibit the endothelium-dependent vasodilation, inhibited increase in mucosal hemodynamics induced by vagal stimulation and acetylcholine.
The Journal of pharmacology and experimental therapeutics  •  1990  |  View Paper
Gossypol (10 microM, 5 min), an inhibitor of endothelium-derived relaxing factor (EDRF) production and/or release, increased basal RVR by 5% and significantly inhibited the vasodilator effects of ACh and ATP but had no effect on verapamil- or GTN-induced decreases in RVR.
The American journal of physiology  •  1990  |  View Paper
Responses to BAEE, BAME, L‐arginine hydrochloride, L‐alanine methylester, L‐methionine methylester, L‐lysine hydroxamate and acetylcholine (but not nitroprusside) were significantly inhibited by CHAPS (4·7 mg mL−1, 30 s) de‐endothelialization as well as pretreatment of mesentery preparations with gossypol (3 μM).
The Journal of pharmacy and pharmacology  •  1989  |  View Paper
In myometrial strips, gossypol (1-30 microM) produced rightward displacements of the cumulative concentration-response curves to acetylcholine , bradykinin and oxytocin, accompanied by reductions in maximal responses.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas  •  1989  |  View Paper
3 Gossypol (3 μm), metyrapone (10 μm) and nordihydroguaiaretic acid, (NDGA, 30 μm), presumed inhibitors of EDRF biosynthesis, reduced or abolished the response to acetylcholine and histamine in perfused kidney and mesentery of the rat without affecting vasodilatation due to nitroprusside.
British journal of pharmacology  •  1988  |  View Paper
The in vivo blood pressure lowering effect of three vasodilators whose in vitro effects are endothelium-dependent acetylcholine , substance P and adenosine triphosphate) was reduced by 40-60% after systemic treatment of the animals with gossypol.
European journal of pharmacology  •  1988  |  View Paper
Show More